BACAMPICILLIN: 18 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
18
Total FAERS Reports
0
Deaths Reported
3
Hospitalizations
18
As Primary/Secondary Suspect
1
Life-Threatening
Approved Prior to Jan 1, 1982
FDA Approved
Discontinued
Status
FDA Application: 050520 ·
First Report: 20151031 · Latest Report: 20200822
What Are the Most Common BACAMPICILLIN Side Effects?
#1 Most Reported
Type iv hypersensitivity reaction
11 reports (61.1%)
#2 Most Reported
Therapeutic product cross-reactivity
9 reports (50.0%)
#3 Most Reported
Rash maculo-papular
8 reports (44.4%)
All BACAMPICILLIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Type iv hypersensitivity reaction | 11 | 61.1% | 0 | 0 |
| Therapeutic product cross-reactivity | 9 | 50.0% | 0 | 0 |
| Rash maculo-papular | 8 | 44.4% | 0 | 0 |
| Oedema | 5 | 27.8% | 0 | 0 |
Who Reports BACAMPICILLIN Side Effects? Age & Gender Data
Gender: 85.0% female, 15.0% male. Average age: 50.4 years. Most reports from: IT. View detailed demographics →
Is BACAMPICILLIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2015 | 1 | 0 | 0 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 0 |
What Is BACAMPICILLIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 13 |
Official FDA Label for BACAMPICILLIN
Official prescribing information from the FDA-approved drug label.